ClinicalTrials.govpublic full text
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
aortic valve stenosis, heart failure, transcatheter aortic valve implantation, heart failure with preserved ejection fraction, sodium-glucose cotransporter-2 inhibitor, transcatheter aortic valve replacement, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 844419
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.